PTC Therapeutics (PTCT) PT Raised to $82 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $69.54 -0.78%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $82.00 (from $70.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Z AI Co Ltd (2513:HK) PT Raised to HK$1,500 at Bernstein SocGen Group
- Morgan Stanley Upgrades Swedbank (SWEDA:SS) (SWDBY) to Equalweight
- CTP NV (CTPNV:NA) PT Lowered to EUR17 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
